Intervention to Hepatic and Pulmonary Metastasis in Breast Cancer Patients
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The number of intervention performed for metastatic breast cancer has dramatically increased
over the past 2 decades. Hepatectomy and pulmonary resection for stage IV colorectal cancer
is now considered the standard of care for resectable patients with isolated hepatic and/or
pulmonary disease and acceptable performance status. However, the indications for resection /
intervention of breast cancer origin metastases are not as clearly defined. The aim of this
study to focus on emerging data for the intervention (resection and/or radiofrequency
ablation (RFA), transcatheter arterial chemoembolization (TACE), cyberKnife stereotactic
radiosurgery) of breast cancer metastatic disease to the lung and liver, with a focus on
indications for resection / intervention.